Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Use of Stem Cell Transplantation for Cell Replacement or Cytoprotective Effect of Microvesicle Released from Mesenchymal Stem Cell

1 Feb 2014

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF) is the most common and severe type of idiopathic interstitial pneumonias (IIP), and which is currently no method was developed to restore normal structure and function. There are several reports on therapeutic effects of adult stem cell transplantations in animal models of pulmonary fibrosis. However, little is known about how mesenchymal stem cell (MSC) can repair the IPF. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Mesenchymal stem cell research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24598998
DOI: 10.14348/molcells.2014.2317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Use of Stem Cell Transplantation for Cell Replacement or Cytoprotective Effect of Microvesicle Released from Mesenchymal Stem CellPMID 24598998Read ↗

The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung DiseasesSemantic proximity Read ↗

Stem-cell extracellular vesicles and lung repairSemantic proximity Read ↗

Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosisSemantic proximity Read ↗

Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.Semantic proximity Read ↗

Mesenchymal Stem Cell Microvesicles Attenuate Acute Lung Injury in Mice Partly Mediated by Ang-1 mRNASemantic proximity Read ↗

Immunity-and-Matrix-Regulatory Cells Derived from Human Embryonic Stem Cells Safely and Effectively Treat Mouse Lung Injury and FibrosisSemantic proximity Read ↗

Mesenchymal stromal cells attenuate pulmonary fibrosis via macrophageSemantic proximity Read ↗

Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosisSemantic proximity Read ↗

Inhalation of mesenchymal stromal cell‐derived extracellular vesicles activates macrophage polarization through the miR-22-3p/NLRP3/IL-1β pathway, ameliorating lung ischemia‒reperfusion injurySemantic proximity Read ↗

Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate Airway Inflammation in a Rat Model of chronic obstructive pulmonary disease (COPD)Semantic proximity Read ↗

Amnion Epithelial Cells as a Candidate Therapy for Acute and Chronic Lung InjurySemantic proximity Read ↗

Endogenous lung stem cells: what is their potential for use in regenerative medicine?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.